Literature DB >> 29052045

Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications.

Antonios Rigas1, Dimitrios Farmakis2, Georgios Papingiotis1, Georgios Bakosis1, John Parissis1.   

Abstract

Neurohumoral activation is an important feature of heart failure. Recent advances in molecular biology and imaging techniques permitted a better understanding of the central role that hypothalamus plays in the modulation of dysfunctional mechanisms, as well as the occurrence of comorbidities, such as depression, in heart failure patients. This review summarizes the commonly reported neural reflexes and molecular signaling pathways at the level of the hypothalamus along with the dysfunctional mechanisms within the paraventricular nucleus and other areas of the hypothalamus in heart failure and describes some relevant therapeutic implications.

Entities:  

Keywords:  Depression; Heart failure; Hypothalamus; Hypothalamus-pituitary axis; Inflammation; Neurohormonal activation

Mesh:

Year:  2018        PMID: 29052045     DOI: 10.1007/s10741-017-9659-7

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  54 in total

Review 1.  Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches.

Authors:  John T Parissis; Katerina Fountoulaki; Ioannis Paraskevaidis; Dimitrios Kremastinos
Journal:  Expert Opin Investig Drugs       Date:  2005-05       Impact factor: 6.206

2.  Cardiac sympathetic afferent stimulation induces salt-sensitive sympathoexcitation through hypothalamic epithelial Na+ channel activation.

Authors:  Koji Ito; Yoshitaka Hirooka; Kenji Sunagawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-19       Impact factor: 4.733

3.  Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits.

Authors:  Yu-Long Li; Xiao-Hong Xia; Hong Zheng; Lie Gao; Yi-Fan Li; Dongmei Liu; Kaushik P Patel; Wei Wang; Harold D Schultz
Journal:  Cardiovasc Res       Date:  2006-03-24       Impact factor: 10.787

4.  Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study.

Authors:  John T Parissis; Dimitrios Farmakis; Maria Nikolaou; Dionysia Birmpa; Vassiliki Bistola; Ioannis Paraskevaidis; Ignatios Ikonomidis; Stavroula Gaitani; Koula Venetsanou; Gerasimos Filippatos; Dimitrios Th Kremastinos
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

5.  Inhibition of Brain Mitogen-Activated Protein Kinase Signaling Reduces Central Endoplasmic Reticulum Stress and Inflammation and Sympathetic Nerve Activity in Heart Failure Rats.

Authors:  Shun-Guang Wei; Yang Yu; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

6.  A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.

Authors:  Stephen S Gottlieb; Willem J Kop; Sue A Thomas; Scott Katzen; Mark R Vesely; Nancy Greenberg; Joanne Marshall; Michelle Cines; Stacey Minshall
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

7.  A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.

Authors:  Renerio Fraguas; Renata Martinho da Silva Telles; Tânia Correa Toledo Ferraz Alves; Anna Maria Andrei; Jairo Rays; Dan V Iosifescu; Mauricio Wajngarten
Journal:  Contemp Clin Trials       Date:  2009-01-24       Impact factor: 2.226

8.  Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure.

Authors:  John T Parissis; Maria Nikolaou; Dimitrios Farmakis; Ioannis A Paraskevaidis; Vassiliki Bistola; Koula Venetsanou; Dimitrios Katsaras; Gerasimos Filippatos; Dimitrios T Kremastinos
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

9.  Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression.

Authors:  John T Parissis; Stamatis Adamopoulos; Antonios Rigas; George Kostakis; Dimitrios Karatzas; Koula Venetsanou; Dimitrios Th Kremastinos
Journal:  Am J Cardiol       Date:  2004-11-15       Impact factor: 2.778

10.  New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.

Authors:  Rosemeire M Kanashiro-Takeuchi; Luca Szalontay; Andrew V Schally; Lauro M Takeuchi; Petra Popovics; Miklos Jaszberenyi; Irving Vidaurre; Marta Zarandi; Ren-Zhi Cai; Norman L Block; Joshua M Hare; Ferenc G Rick
Journal:  Oncotarget       Date:  2015
View more
  4 in total

1.  Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele.

Authors:  Andrea J Korecki; Jack W Hickmott; Siu Ling Lam; Lisa Dreolini; Anthony Mathelier; Oliver Baker; Claudia Kuehne; Russell J Bonaguro; Jillian Smith; Chin-Vern Tan; Michelle Zhou; Daniel Goldowitz; Jan M Deussing; A Francis Stewart; Wyeth W Wasserman; Robert A Holt; Elizabeth M Simpson
Journal:  Genetics       Date:  2019-02-14       Impact factor: 4.562

2.  Obesity and Uncontrolled Diabetes Predict Depression in HF Patients.

Authors:  Albenita Fetahu; Kaltrinë Rrustemi; Michael Y Henein; Besim Bytyçi; Flamure Mehmeti; Ibadete Bytyçi; Lulzim Kamberi
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

Review 3.  Protective Effect of Natural Medicinal Plants on Cardiomyocyte Injury in Heart Failure: Targeting the Dysregulation of Mitochondrial Homeostasis and Mitophagy.

Authors:  Qi Wang; Hao Su; Jinfeng Liu
Journal:  Oxid Med Cell Longev       Date:  2022-09-12       Impact factor: 7.310

Review 4.  Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure.

Authors:  Lizhen Chen; Dayun Yu; Shuang Ling; Jin-Wen Xu
Journal:  Front Cardiovasc Med       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.